Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 4 (2007), Issue 10 (October)

1. Retinoic acid inhibits beta-catenin through suppression of Cox-2: a role for truncated adenomatous polyposis coli.
   J Biol Chem, 282(40): 29394-400. [Abstract] [Full-text]
2. A lipophilic statin, pitavastatin, suppresses inflammation-associated mouse colon carcinogenesis.
   Int J Cancer, 121(10): 2331-9. [Abstract] [Full-text]
3. Differential involvement of destrin and cofilin-1 in the control of invasive properties of Isreco1 human colon cancer cells.
   Int J Cancer, 121(10): 2162-71. [Abstract] [Full-text]
4. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells.
   Int J Cancer, 121(10): 2140-52. [Abstract] [Full-text]
5. Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies.
   J Natl Cancer Inst, 99(19): 1471-83. [Abstract] [Full-text]
6. Primer: Applying the new postpolypectomy surveillance guidelines in clinical practice.
   Nat Clin Pract Gastroenterol Hepatol, 4(10): 571-8. [Abstract] [Full-text]
7. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
   Cancer Res, 67(19): 9568-76. [Abstract] [Full-text]
8. Serial assessment of human tumor burdens in mice by the analysis of circulating DNA.
   Cancer Res, 67(19): 9364-70. [Abstract] [Full-text]
9. beta-catenin regulates multiple steps of RNA metabolism as revealed by the RNA aptamer in colon cancer cells.
   Cancer Res, 67(19): 9315-21. [Abstract] [Full-text]
10. Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.
    Cancer Res, 67(19): 9286-93. [Abstract] [Full-text]
11. Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin.
    Cancer Chemother Pharmacol, 61(1): 105-11. [Abstract] [Full-text]
12. Multiple lymphomatous diverticulosis and comorbid chronic lymphocytic leukemia: novel manifestations of ileocolic mantle cell lymphoma.
    Int J Surg Pathol, 15(4): 408-13. [Abstract] [Full-text]
13. Primary malignant melanoma of the transverse colon: report of a case and review of the literature.
    Int J Surg Pathol, 15(4): 401-7. [Abstract] [Full-text]
14. Comparison of laparoscopic vs open sigmoid colectomy for benign and malignant disease at academic medical centers.
    J Gastrointest Surg, 11(11): 1423-9; discussion 1429-30. [Abstract] [Full-text]
15. Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP.
    Mol Immunol, 45(3): 796-804. [Abstract] [Full-text]
16. Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers.
    Genes Chromosomes Cancer, 46(12): 1061-8. [Abstract] [Full-text]
17. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
    Genes Chromosomes Cancer, 46(12): 1080-9. [Abstract] [Full-text]
18. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.
    J Clin Oncol, 25(29): 4569-74. [Abstract] [Full-text]
19. Outcomes of Veterans Affairs patients older than age 80 after surgical procedures for colon malignancies.
    Am J Surg, 194(5): 646-51. [Abstract] [Full-text]
20. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.
    Gut, 56(11): 1557-63. [Abstract] [Full-text]
21. Colorectal intussusception secondary to sigmoid carcinoma in an adult.
    South Med J, 100(10): 1039-41. [Abstract] [Full-text]
22. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
    J Surg Res, 143(1): 58-65. [Abstract] [Full-text]
23. A urokinase-type plasminogen activator deficiency diminishes the frequency of intestinal adenomas in ApcMin/+ mice.
    J Pathol, 213(3): 266-74. [Abstract] [Full-text]
24. Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis.
    Cancer, 110(9): 1945-50. [Abstract] [Full-text]
25. Increased susceptibility of Sf1(+/-) mice to azoxymethane-induced colon tumorigenesis.
    Cancer Sci, 98(12): 1862-7. [Abstract] [Full-text]
26. Extracellular and transmembrane region of a podocalyxin-like protein 1 fragment identified from colon cancer cell lines.
    Cell Biol Int, 31(12): 1518-24. [Abstract] [Full-text]
27. Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice.
    Int J Radiat Oncol Biol Phys, 69(4): 1231-7. [Abstract] [Full-text]
28. Leisure-time physical activity patterns and risk of colon cancer in women.
    Int J Cancer, 121(12): 2776-81. [Abstract] [Full-text]
29. Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation.
    Int J Cancer, 121(12): 2808-14. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.